Copyright
©The Author(s) 2021.
World J Exp Med. Sep 20, 2021; 11(4): 44-54
Published online Sep 20, 2021. doi: 10.5493/wjem.v11.i4.44
Published online Sep 20, 2021. doi: 10.5493/wjem.v11.i4.44
Table 1 Demographic and clinical characteristics of serologically positive reverse transcription polymerase chain reaction negative coronavirus disease 2019 patients
| n (%) | |
| Agein yr | |
| mean ± SD | 63.2 ± 13.1 |
| Gender | |
| Male/Female | 11/11 |
| Symptoms, n (%) | |
| Cough | 20 (90.9) |
| Dyspnea | 14 (63.6) |
| Fever | 10 (45.4) |
| Chest pain | 8 (36.3) |
| Duration in d, mean ± SD | |
| From first symptom to admission | 8.6 ± 7.2 |
| Hospital stay | 11.2 ± 5.4 |
| From symptoms to antibody test | 24 ± 17 |
| Drug treatment | 7.9 ± 3.2 |
- Citation: Yıldırım F, Gulhan PY, Diken ÖE, Capraz A, Simsek M, Yildirim BB, Taysi MR, Ozturk SY, Demirtas N, Ergil J, Dirican A, Uzar T, Karaman I, Ozkaya S. Role of serological rapid antibody test in the management of possible COVID-19 cases. World J Exp Med 2021; 11(4): 44-54
- URL: https://www.wjgnet.com/2220-315x/full/v11/i4/44.htm
- DOI: https://dx.doi.org/10.5493/wjem.v11.i4.44